Our Mission

PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.

Click the orange button to the right to learn more.

Search Results for: chemotherapy induced peripheral neu

MM Dx, MM CC, Induction, ASCT, Healing, Surviving-Now What?

Hi David- I trust you are well. Thank you again for all of the information you share through your Mighty Networks Online group and MM Cancer Coaching (MM CC) Program.  It has certainly helped me support

Continue reading

Multiple Myeloma Side Effects- Heal Chemobrain, Dementia

“These satisfactory results confirm the therapeutic importance of acetyl-L-carnitine in the treatment of elderly patients with mental impairment…” Cognitive decline, chemobrain, post-chemotherapy

Continue reading

Bladder Cancer Therapy beyond Bacillus Calmette-Guérin (BCG)

The agent (CG0070) yielded an overall 12-month complete response (CR) rate of 30% in a phase 2 single-arm trial in patients with BCG-unresponsive, high-grade Ta, T1, or CIS ± Ta/T1 non-muscle-invasive

Continue reading

Multiple Myeloma Therapy- Thymoquinone

Our results show that Thymoquinone inhibited the proliferation of MM cells irrespective of their sensitivity to doxorubicin, melphalan or bortezomib… If you’ve been diagnosed with multiple

Continue reading

Myeloma- ASCT = Chemo Fatigue not MM

“Fatigue ranks as perhaps the most prevalent of cancer complaints — studies over the past two decades have confirmed it as a significant problem during and for some years after treatment ends…” In

Continue reading

Multiple Myeloma Remission- QOL or PFS?

Long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy. For newly diagnosed myeloma patients the concept of remission is somewhat complicated.

Continue reading

Myeloma Diagnosis- RVd, ASCT, Now or Later?

In conclusion, we found no statistically significant differences in (MM) PFS and OS between the early versus late ASCT groups. Hi David-My father in-law  just emailed me your newly-updated Multiple Myeloma

Continue reading

Multiple Myeloma Diagnosis- “My dad- 70, SBP, now full blown MM?

Seems like my dad’s multiple myeloma has become active again. I Wanna know best treatment options from your experience and research My dad had solitary plasmacytoma in November 2015 in his  T8-T10

Continue reading

End Stage Myeloma- Hospice or Home?

“In addition to quality-of-life improvements, enrolling appropriate patients with multiple myeloma into hospice may also have cost implications, a new study found.” No multiple myeloma (MM)

Continue reading

Surviving Cancer- Scalp cooling, Alopecia

"Scalp cooling is a 'viable and effective method' for preventing hair loss during cancer treatments and does not appear to pose a risk for scalp metastases, concluded a US overview of 83

Continue reading

Multiple Myeloma Treatment Side Effects

Knowledge is Power When considering Conventional Multiple Myeloma Therapy If you are reading this blog post, then you probably have been diagnosed with multiple myeloma, have undergone one or more conventional

Continue reading

Hospitalized for Multiple Myeloma ASCT? Try Yoga-

Hospitalized patients receiving treatment for hematological cancer (MM) were provided a 40-minute individualized yoga therapy session… The key to managing multiple myeloma (MM), especially if you

Continue reading